Atiprimod

DB05513InvestigationalSmall molecule

Investigated for use/treatment in cancer/tumors (unspecified), multiple myeloma, and rheumatoid arthritis.

Chemical structure of Atiprimod
Primary indication
Investigated for use/treatment in cancer/tumors (unspecified), multiple myeloma, and rheumatoid arthritis.Curator reviewed
Formula / weight
C22H44N2 · 336.608 g/mol (avg)
Also known as
2-(3-(DIETHYLAMINO)PROPYL)-8,8-DIPROPYL-2-AZASPIRO(4.5)DECANE · 2-(3-diethylaminopropyl)-8,8-dipropyl-2-azaspiro [4,5] decan dimaleate · 2-AZASPIRO(4.5)DECANE-2-PROPANAMINE N,N-DIETHYL-8,8-DIPROPYL- · Azaspirane
Code names
SK&F-106615

Resolves to

Compound
UNIIMG7D3QD743CAS123018-47-3ChEMBLCHEMBL103735
Structure
InChIKeySERHTTSLBVGRBY-UHFFFAOYSA-NSMILESCCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1
Targets
P40763STAT3P05231IL6P01375TNF

What you can answer from here — as of September 16, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Atiprimod, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In